All AbMole products are for research use only, cannot be used for human consumption.
APO866 (FK866) (0.09-27 nM) induces dose-dependent cytotoxicity in 41 hematologic malignant cells including acute myeloid leukemia, acute lymphoblastic leukemia, mantle cell lymphoma, chronic lymphocytic leukemia, and T-cell lymphoma. APO866 (FK866) (0-10 nM) dose-dependently induces depletion of intracellular NAD and ATP contents and cell death in various hematologic cancer cells. APO866 (FK866) (10 nM) inhibits PBEF-induced secretion of MMP-3, CCL2, and CXCL8 in HFFF2 cells. APO866 administered intraperitoneally at dose of 20 mg/kg twice a day for 4 days, repeat weekly over 3 weeks, prevents and abrogats tumor growth in C.B.-17 SCID mice xenograft models of human AML, lymphoblastic lymphoma, and leukemia.
 |
Source | Int J Mol Med (2017). Figure 4. FK866 |
| Method | flow cytometry | |
| Cell Lines | Endothelial progenitor cells | |
| Concentrations | 10 μM | |
| Incubation Time | 48 h | |
| Results | Recombinant human visfatin induced a dose-dependent and significant increase in EPC apoptosis, and this effect was completely abrogated by pre-treatment with FK866. |
| Cell Experiment | |
|---|---|
| Cell lines | |
| Preparation method | |
| Concentrations | |
| Incubation time | |
| Animal Experiment | |
|---|---|
| Animal models | BALB/c nude or nonleaky C.B.-17 SCID mice (6 to 10 weeks old) |
| Formulation | in 200 uL 0.9% saline |
| Dosages | 20 mg/kg, twice a day for 4 days, repeated weekly over 3 weeks |
| Administration | intraperitoneally |
| Molecular Weight | 391.51 |
| Formula | C24H29N3O2 |
| CAS Number | 658084-64-1 |
| Solubility (25°C) | Ethanol 48 mg/mL DMSO 48 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related Transferase Products |
|---|
| P053
P053 is a potent, non-competitive and selective ceramide synthase 1 (CerS1) inhibitor wirh an IC50 of 0.5 μM. P053 also acts as an endogenous inhibitor of mitochondrial fatty acid oxidation in muscle. |
| ABT-046
ABT-046 is a potent, selective, and orally active acyl CoA:diacylglycerol acyltransferase 1 (DGAT-1) inhibitor with IC50s of both 8 nM against human and mouse DGAT-1. |
| JTP-103237
JTP-103237 is a MGAT2 inhibitor (IC50: 0.019 μM and 6.423 μM for hMGAT2 and hMGAT3 respectively). |
| PF-06424439
PF-06424439 is an oral, potent and selective imidazopyridine diacylglycerol acyltransferase 2 (DGAT2) inhibitor with an IC50 of 14 nM. |
| POP-3MB
POP-3MB is an ICMT inhibitor (IC50: 2.5 μM). |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
